Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Next Previous
Trial Profile

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Somapacitan (Primary)
  • Indications Somatotropin deficiency
  • Focus Pharmacokinetics
  • Sponsors Novo Nordisk

Most Recent Events

  • 23 Mar 2021 Results assessing impact of kidney or hepatic impairment on somapacitan exposure in adults.in two studies (NCT03186495 & NCT03212131), published in the Clinical Pharmacokinetics.
  • 01 Jun 2018 Status changed from active, no longer recruiting to completed.
  • 13 Apr 2018 Planned primary completion date changed from 25 Apr 2018 to 16 May 2018.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top